Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Voltarol Pain-eze Extra Strength 25mg tablets
1001010AGBCABAA
|
Voltarol Pain-eze | Diclofenac potassium | Musculoskeletal and Joint Diseases | No data available |
|
Voltarol Rapid 25mg tablets
1001010AGBBAAAA
|
Voltarol Rapid | Diclofenac potassium | Musculoskeletal and Joint Diseases | No data available |
|
Voncento 1,000unit / 2,400unit inj vials
0211000I0BQAAAM
|
Voncento | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Voncento 500unit / 1,200unit inj vials
0211000I0BQABAB
|
Voncento | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Voractiv (Imported)
0501090S0BEABA0
|
Voractiv | Rifampicin combined preparations | Infections | No data available |
|
Voriconazole 1% eye drops
0502010D0AAAGAG
|
Voriconazole | Voriconazole | Infections | No data available |
|
Voriconazole 1% eye drops preservative free
0502010D0AAAEAE
|
Voriconazole | Voriconazole | Infections | No data available |
|
Voriconazole 200mg inj vials
0502010D0AAAFAF
|
Voriconazole | Voriconazole | Infections | No data available |
|
Voriconazole 200mg powder for solution for infusion vials
0502010D0AAACAC
|
Voriconazole | Voriconazole | Infections | No data available |
|
Vortex Spacer
21010230133
|
Vortex Spacer | Other Appliances | Appliances | No data available |
|
Vortex with adult mask
21010230129
|
Vortex with adult mask | Other Appliances | Appliances | No data available |
|
Vortex with baby mask 0-2 years
21010230131
|
Vortex with baby mask 0-2 years | Other Appliances | Appliances | No data available |
|
Vortex with child mask 2 years+
21010230132
|
Vortex with child mask 2 years+ | Other Appliances | Appliances | No data available |
|
Vosevi 400mg/100mg/100mg tablets
0503032L0BBAAA0
|
Vosevi | Sofosbuvir/velpatasvir/voxilaprevir | Infections | No data available |
|
Votrient 200mg tablets
0801050AZBBAAAA
|
Votrient | Pazopanib | Malignant Disease and Immunosuppression | No data available |
|
Votrient 400mg tablets
0801050AZBBABAB
|
Votrient | Pazopanib | Malignant Disease and Immunosuppression | No data available |
|
Votubia 10mg tablets
0801050AXBCACAB
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 2.5mg tablets
0801050AXBCABAC
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 2mg dispersible tablets
0801050AXBCADAG
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 3mg dispersible tablets
0801050AXBCAEAH
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 5mg dispersible tablets
0801050AXBCAFAI
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 5mg tablets
0801050AXBCAAAA
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
VSL#3 Food Supplement capsules
0913531B0BIAAAH
|
VSL#3 capsules delisted probiotic | Capsules delisted probiotic (0913531) | Nutrition and Blood | No data available |
|
VSL#Fibre Experience Food Supplement oral powder 4g sachets
0913531C0BCABAE
|
VSL powder delisted probiotic | Powder delisted probiotic (0913531) | Nutrition and Blood | No data available |
|
Vyndaqel 20mg capsules
0409030S0BBAAAA
|
Vyndaqel (old) | Tafamidis meglumine (old) | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.